Literature DB >> 18069666

Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.

Kiran K Mantripragada1, Matthew Caley, Phil Stephens, Christopher J Jones, Lan Kluwe, Abhijit Guha, Victor Mautner, Meena Upadhyaya.   

Abstract

Telomerase activity (TA) and the expression of its enzymatic subunits, which have been demonstrated in many tumors, remain poorly investigated in tumors associated with neurofibromatosis type 1 (NF1). In this study, we analysed the association of TA and the expression of telomerase RNA (TR) and telomerase reverse transcriptase (TERT) in 23 malignant peripheral nerve sheath tumors (MPNST) (17 high grade and 6 low grade tumors), 11 plexiform neurofibromas (PNF) and 6 dermal neurofibromas (DNF). TA was studied using telomerase repeat amplification protocol (TRAP) assay and expression of TR and TERT was investigated using reverse transcription PCR (RT-PCR) and real-time PCR. TA was detected in 14 out of 17 (82%) high grade MPNST, whereas all 6 low grade MPNST and 17 benign tumors were telomerase negative. The TERT transcripts were detected in all high grade MPNST, 50% of the low grade MPNST, and 4 benign tumors. However, the expression level of the TERT strikingly correlated with TA and high grade MPNST. Thus, while TERT expression was similar in both low grade MPNST and PNF (P = 0.115), it was significantly higher in high grade MPNST when compared to either low grade MPNST (P = 0.042), PNF (P = 0.001) or DNF tumors (P = 0.010). These findings indicate that TA and expression level of TERT are potential markers for high grade malignancy in NF1 patients. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18069666     DOI: 10.1002/gcc.20525

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

Review 1.  Emerging therapeutic targets for neurofibromatosis type 1.

Authors:  James A Walker; Meena Upadhyaya
Journal:  Expert Opin Ther Targets       Date:  2018-05-07       Impact factor: 6.902

2.  Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.

Authors:  Lorenza Venturini; Maria Grazia Daidone; Rosita Motta; Graziella Cimino-Reale; Stacey F Hoare; Alessandro Gronchi; Marco Folini; William Nicol Keith; Nadia Zaffaroni
Journal:  Neuro Oncol       Date:  2012-04-19       Impact factor: 12.300

3.  TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.

Authors:  Hendrikus J Dubbink; Hannah Bakels; Edward Post; Ellen C Zwarthoff; Robert M Verdijk
Journal:  J Neurooncol       Date:  2014-07-18       Impact factor: 4.130

Review 4.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

5.  FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer.

Authors:  Minlu Huang; Xinjie Ma; Hongpeng Shi; Lei Hu; Zhiyuan Fan; Li Pang; Fan Zhu; Xiao Yang; Wei Xu; Binya Liu; Zhenggang Zhu; Chen Li
Journal:  Oncotarget       Date:  2017-08-10

6.  Telomere erosion in NF1 tumorigenesis.

Authors:  Rhiannon E Jones; Julia W Grimstead; Ashni Sedani; Duncan Baird; Meena Upadhyaya
Journal:  Oncotarget       Date:  2017-06-20

7.  Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers.

Authors:  Zhao Zhang; Youqiong Ye; Jing Gong; Hang Ruan; Chun-Jie Liu; Yu Xiang; Chunyan Cai; An-Yuan Guo; Jiqiang Ling; Lixia Diao; John N Weinstein; Leng Han
Journal:  Commun Biol       Date:  2018-12-21

8.  Telomere alterations in neurofibromatosis type 1-associated solid tumors.

Authors:  Fausto J Rodriguez; Mindy K Graham; Jacqueline A Brosnan-Cashman; John R Barber; Christine Davis; M Adelita Vizcaino; Doreen N Palsgrove; Caterina Giannini; Melike Pekmezci; Sonika Dahiya; Murat Gokden; Michael Noë; Laura D Wood; Christine A Pratilas; Carol D Morris; Allan Belzberg; Jaishri Blakeley; Christopher M Heaphy
Journal:  Acta Neuropathol Commun       Date:  2019-08-28       Impact factor: 7.578

9.  Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders.

Authors:  Maha Mohamed Farid Aql; Seham Abd-El Ghafour Bahget; Naglaa Kholoussi; Ghada Mohamed El Hossiny Abdel-Salam; Haiam Abdel Raouf; Maha Mohamed Eid; Rania El-Bialy Esmail
Journal:  Int J Mol Cell Med       Date:  2021-05-22

10.  TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.

Authors:  Christian Koelsche; Marcus Renner; Wolfgang Hartmann; Regine Brandt; Burkhard Lehner; Nina Waldburger; Ingo Alldinger; Thomas Schmitt; Gerlinde Egerer; Roland Penzel; Eva Wardelmann; Peter Schirmacher; Andreas von Deimling; Gunhild Mechtersheimer
Journal:  J Exp Clin Cancer Res       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.